News Releases

The following news releases are issued by GlaxoSmithKline Inc. In addition to these resources, you may also find GlaxoSmithKline global news of interest.

February 9, 2010

Health Canada approves CERVARIX™, new GSK cervical cancer vaccine

November 3, 2009

ViiV Healthcare Launches - A new specialist HIV company dedicated to delivering advances in HIV treatment and care.
CEO promises ‘relentless pursuit’ of new treatments

October 19, 2009

Setting the record straight: GlaxoSmithKline continues to facilitate the use of Canada's Access to Medicines Regimes to enable the export of HIV/AIDS drug to Rwanda

October 13, 2009

GSK’s Avodart® / tamsulosin combination showed benefits for men with prostate enlargement

July 22, 2009

GlaxoSmithKline Completes Acquisition of Stiefel

July 7, 2009

Largest efficacy trial of a cervical cancer vaccine showed Cervarix™ protects against the five most common cancer causing virus types

June 5, 2009

Large, long-term study shows AVANDIA® has no increased overall cardiovascular risk compared to other commonly used diabetes medicines

May 26, 2009

New therapy option for advanced HER2 breast cancer approved in Canada

May 13, 2009

New professorship for McGill Faculty of Medicine

May 12, 2009

CERVARIX™ SHOWS SIGNIFICANTLY HIGHER IMMUNE RESPONSE IN HEAD-TO-HEAD TRIAL OF THE TWO CERVICAL CANCER VACCINES

April 20, 2009

GlaxoSmithKline and Stiefel to create new world-leading specialist dermatology business

February 25, 2009

B.C. babies get a break: Introduction of new infant vaccine means three fewer injections

January 30, 2009

New research chair in chronic obstructive pulmonary disease

January 5, 2009

GlaxoSmithKline recognized as one of the 50 Best Employers in Canada